Examination of the mizoribine and azathioprine combination immunosuppressive therapy in primary sclerosing cholangitis Examination of the mizoribine and azathioprinecombination immunosuppressive therapy in primary scler ...
Examination of the immunosuppressive drug combination therapy in primary sclerosing cholangitisStudy of the mizoribine and azathioprine combination immunosuppressive therapy - Examination of the immunosuppressive drug combination therapy in primary sclerosing cholangitis Examination of the immunosuppressive drug combination therapy in primary sclerosing cholangitisStudy ...
Primary sclerosing cholangitis; PSC;K830
1 MZR Daily intake of mizoribine once before breakfast. Dose adjustment is done to achieve a blood concentration level over 3.0 microg/ml at 3 hour after meal. 2)AZT Daily intake of azathioprine once after breakfast and once after dinner. Starting dose is 0.5-1.0mg/kg daily (max 2.0mg) , is increased according to the condition of patients. Dose is adjusted to achieve WBC 3000-5000/m3, neutrophils 2000-3500/m3(the dose of 6MP is appotoimatery half of azathioprine). Continue the dosage during a study period. 1 MZR Daily intake of mizoribineonce before breakfast. Dose adjustment is done to achieve a blood con ...
Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter study for combination immunosuppressive therapy with mizoribine and azathioprine - Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter stu ...
Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter study for combination immunosuppressive therapy with mizoribine and azathioprine - - Study of combination immunosuppressive therapy in primary sclerosing cholangitis Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter stu ...